Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin

• 主要な著者: Daniel A. Kelmenson MD (著者), Kelsey Burr MD (著者), Yusra Azhar MBBS (著者), Paul Reynolds PharmD, BCPS (著者), Chelsea A. Baker MS, MPAS (著者), Neda Rasouli MD (著者)
• フォーマット: 図書
• 出版事項: SAGE Publishing, 2017-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control by a reversible inhibition of the sodium-glucose cotransporters in the renal proximal tubules resulting in increased urinary glucose. This unique mechanism, independent of insulin secretion and beta cell function, has made th...